NVO - Novo Nordisk announces limited launch of Wegovy in U.K.
2023-09-05 07:44:29 ET
More on Novo Nordisk
- Novo Nordisk briefly dethrones LVMH as EU's most valuable company
- Study finds Wegovy least cost-effective drug option for teen weight loss
- Novo Nordisk: Super Focused Pharma Company For The Long Run
- Novo Nordisk: Strong Fundamentals Meet Technical Uptrends
- Lilly & Novo: Are Weight Loss Drugs A Global Revolution Or Short-Lived Fad?
For further details see:
Novo Nordisk announces limited launch of Wegovy in U.K.